Nutrient Supplementation Influences Mitochondria Adaptation

May 12, 2020 updated by: Mette Hansen, University of Aarhus

Effect of Whey Protein Hydrolysate on Adaptions to Endurance Training in Well-trained Runners

Twenty-four well trained runners (VO2max 60.73.7 ml O2 Kg-1 min1) completed a six week block randomized controlled intervention period. Subjects were randomly assigned to either PRO-CHO or CHO and matched in pairs for gender, age, VO2max, training and performance status. The PRO- CHO group ingested a protein beverage (0.3g kg-1) before and protein-carbohydrate beverage (0.3g protein kg-1 and 0.1g carbohydrate kg-1) after each exercise session. The CHO group ingested energy matched carbohydrate. Post-absorptive muscle biopsies were obtained pre and post intervention for analysis HAD, CS and PGC-1. Subjects completed two physical tests 6 km performance test (pre, week 1 and week 6) and aVo2max test (pre and post intervention).

Study Overview

Study Type

Interventional

Enrollment (Actual)

24

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Aarhus, Denmark, 8000
        • Aarhus University, Department for Public Health, Section for Sport Science
      • Aarhus, Denmark, 8000
        • Sport Science, Department of Public Health, Aarhus University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 55 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. maximal oxygen uptake (VO2max) of >50ml O2 kg-1 min-1 for women and >55ml O2 kg-1 min-1 for men,
  2. running at least 3 times a week and
  3. running being the primarily training form

Exclusion Criteria:

  1. use of medicine
  2. diagnosed metabolic diseases
  3. injuries which hindered running and body mass index (BMI) < 25 kg m-2

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: PROTEIN-CARBOHYDRATE
Intervention group receiving protein and carbohydrate supplement
PRO before and PRO-CHO after training
Placebo Comparator: CARBOHYDRATE
Intervention groups receiving carbohydrate supplement
CHO before and after training

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maximal oxygen uptake
Time Frame: Change from week 1 to week 6
maximal oxygen uptake (L O2/min)
Change from week 1 to week 6

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
VDAC
Time Frame: Change from week 1 to week 6
Mitochondria target measured by western blotting
Change from week 1 to week 6
CytC
Time Frame: Change from week 1 to week 6
Mitochondria enzyme measured by western blotting
Change from week 1 to week 6
Performance
Time Frame: Change from week 1 to week 6
6 km trial test
Change from week 1 to week 6
COX-IV
Time Frame: Change from week 1 to week 6
Mitochondria target measured by western blotting
Change from week 1 to week 6
HSP60
Time Frame: Change from week 1 to week 6
Mitochondria target measured by western blotting
Change from week 1 to week 6
CD36
Time Frame: Change from week 1 to week 6
Fat transporter measured by western blotting
Change from week 1 to week 6

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2013

Primary Completion (Actual)

February 1, 2014

Study Completion (Actual)

June 1, 2014

Study Registration Dates

First Submitted

December 1, 2017

First Submitted That Met QC Criteria

June 7, 2018

First Posted (Actual)

June 19, 2018

Study Record Updates

Last Update Posted (Actual)

May 14, 2020

Last Update Submitted That Met QC Criteria

May 12, 2020

Last Verified

May 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • AURunners2017

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Performance

Clinical Trials on PROTEIN-CARBOHYDRATE

Subscribe